Kaili Medical's Extraordinary Shareholders' Meeting Passes the Share Repurchase Plan with a 99.99% Approval Rate

MaticHoleFiller · 2026-04-04T15:31:48+00:00

On April 3, 2026, Shenzhen Kaili Biomedical Technology Co., Ltd. (Stock Code: 300633, Stock Abbreviation: Kaili Medical) held an extraordinary general meeting of shareholders through a combination of on-site voting and online voting. The meeting was convened by the company's board of directors, chaired by Chairman Chen Zhiqiang, and held at Conference Room 121, 1st Floor, Kaili Medical Building, No. 368 Optoelectronics North Road, Guangming District, Shenzhen.A total of 156 shareholders and shareholder proxy representatives attended the meeting, representing 235,928,462 shares with voting rights, accounting for 54.8260% of the company's total voting shares. Among them, 4 attended the on-site meeting, representing 219,547,753 shares; 152 participated via online voting, representing 16,380,709 shares. Company directors attended the meeting, and senior management personnel were present. Beijing Zhonglun (Shenzhen) Law Firm acted as legal counsel.

MaticHoleFiller

2026-04-04 15:31:48

On April 3, 2026, Shenzhen Kaile Medical Bio-Technology Co., Ltd. (Security Code: 300633, Stock Short Name: Kaile Medical) convened an extraordinary shareholders’ meeting in a hybrid format combining onsite voting and online voting. The meeting was convened by the company’s board of directors, chaired by Chairman Chen Zhiqiang. The venue was the 121 Meeting Room on the first floor of the Kaile Medical Building, 368 Guangdian North Road, Guangming District, Shenzhen.

A total of 156 shareholders and authorized proxies of shareholders attended this meeting, representing 235,928,462 shares with voting rights, accounting for 54.8260% of the company’s total shares with voting rights. Among them, 4 persons attended the onsite meeting, representing 219,547,753 shares; 152 persons attended via online voting, representing 16,380,709 shares. The company’s directors attended the meeting, senior management personnel attended as observers, and lawyers from Beijing Zhonglun (Shenzhen) Law Firm witnessed the meeting.

The meeting deliberated on and, item by item, approved the “Proposal on the Company’s Share Repurchase Plan.” The voting results for each sub-proposal are as follows:

Sub-proposal Number
Sub-proposal Name
Total Yes Shares (Shares)
Total Yes Rate
Yes Shares of Small and Medium Shareholders (Shares)
Yes Rate of Small and Medium Shareholders
Voting Result
—
1.01
Purpose of the Share Repurchase
235,902,762
99.9891%
16,355,009
99.8431%
Passed
1.02
Explanation of How the Share Repurchase Meets Relevant Conditions
235,896,762
99.9866%
16,349,009
99.8065%
Passed
1.03
Repurchase Method and Price Range
235,896,762
99.9866%
16,349,009
99.8065%
Passed
1.04
Type, Use, Quantity of the Proposed Repurchased Shares, Proportion of Total Company Share Capital, and Total Amount of Funds Proposed for Repurchase
235,896,762
99.9866%
16,349,009
99.8065%
Passed
1.05
Source of Funds for the Share Repurchase
235,902,662
99.9891%
16,354,909
99.8425%
Passed
1.06
Implementation Period of the Share Repurchase
235,902,762
99.9891%
16,355,009
99.8431%
Passed
1.07
Specific Authorization for Handling Matters Related to This Share Repurchase
235,896,762
99.9866%
16,349,009
99.8065%
Passed

Beijing Zhonglun (Shenzhen) Law Firm issued a legal opinion stating that the procedures for convening and holding this shareholders’ meeting, the qualifications of persons attending or attending as observers, and the voting procedures and results all comply with relevant laws and regulations and the provisions of the company’s articles of association. They are lawful and effective.

Statement: There are risks in the market; investing requires caution. This article is automatically published by an AI large model based on third-party databases and does not represent Sina Finance’s viewpoint. Any information appearing in this article is only for reference and does not constitute personal investment advice. If there is any discrepancy, please refer to the actual announcements. If you have any questions, please contact biz@staff.sina.com.cn.

All the news and detailed analysis—right in the Sina Finance app

Responsible editor: Xiao Lang Express

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.